Pay in 4 interest-free payments of $6.70 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
NDI-010976 is an inhibitor of both ACC1 and ACC2, which was well tolerated and resulted in profound dose-dependent inhibition of hepatic de novo lipogenesis in overweight male adults in a randomized, controlled crossover trial
Users are essentially participating in uncontrolled self-experimentation, and should proceed with appropriate caution
It also upregulates antioxidant enzymes including superoxide dismutase (SOD) and catalase
10.1111/bph.15059 73 ZhangL.LiC.ZhangZ.ZhangZ.JinQ
US$ 22.51
US$ 26.61
US$ 25.33
